newsfilter
← Latest News
GlobeNewswire·

Korro to Present at the 2026 Jefferies Global Healthcare Conference

  • Korro Bio, Inc. (NASDAQ: KRRO) announced that CEO Ram Aiyar, Ph.D., will present at the 2026 Jefferies Global Healthcare Conference in New York, NY.
  • The presentation is scheduled for Thursday, June 4, 2026, at 4:20 pm ET.
  • Korro utilizes its proprietary OPERA® platform to develop genetic medicines for rare & highly prevalent diseases by editing RNA instead of DNA.
  • The OPERA® platform enables precise, tissue-directed single base edits to produce therapeutic proteins with enhanced functionality using ADAR proteins & machine learning.
  • Korro plans to deliver medicines via subcutaneous administration using N-acetylgalactosamine (GalNAc) conjugates & established regulatory pathways.
  • The company is based in Cambridge, Massachusetts, & discloses material information via its Investor Relations website, LinkedIn, & X (Twitter).
  • Investor & media inquiries should contact Malini Chatterjee, Ph.D., at Blueprint Life Science Group via mchatterjee@bplifescience.com or 917.330.4269.